-
Fashion brand Badblood under fire for ‘blackfishing’ on InstagramRetailFeb 28, 2021Asian model’s skin darkened to make clothes ‘look even better’ -
Green Cross subsidiary secures $120m investmentTechnologyFeb 28, 2021Artiva Biotherapeutics, a subsidiary of South Korean pharmaceutical firm Green Cross, announced Sunday that it has secured $120 million in Series B financing to develop natural killer (NK) cell-based cancer therapies. Artiva Biotherapeutics said its new investor Venrock Healthcare Capital Partners has led the latest financing. Other new investors include Acuta Capital Partners, Cormorant Asset Management, EcoR1 Capital, Franklin Templeton, according to the company. The injection of fresh cap -
Celltrion founder’s first son to join boardroomTechnologyFeb 28, 2021Celltrion founder and Chairman Seo Jung-jin’s eldest son Seo Jin-seok is expected to obtain a seat in the company’s boardroom next month, industry sources said on Sunday. Celltrion is to finalize the appointment of the junior Seo as representative director at the shareholder meeting scheduled on March 26, the sources added. The first son has been serving as senior vice president for Celltrion since 2017. Seo Jin-seok also spearheaded Celltrion Skin Cure, the group’s cosmeti
![[From the scene] Seoul’s newest, biggest department store offers new shopping experience](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=655&simg=/content/image/2021/02/26/20210226000443_0.jpg)